DIER MARDI (EVP and CFO) sold 11.3% of their position (1.18K shares) of MADRIGAL PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $505.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/2/2026ACC: 0001628280-26-013394
Officer· EVP and CFO
Since Mar 2026
-1.18K
Net shares
Net seller
$505.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.18K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.18K
Price / share
$427.21
Trade value
$505.39K
% of position
11.3%
3/2/2026
10.44K→9.26K
Total
Net shares
−1.18K
Net value
-$505.39K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | S · Sale | −1.18K | $427.21 | $505.39K | 11.3% | 10.44K | 9.26K |
| Total | −1.18K | -$505.39K | ||||||
Derivative Transactions0
No derivative transactions reported